Anatomy & Physiology: The Unity of Form and Function (Standalone Book)
7th Edition
ISBN: 9780073403717
Author: Kenneth S. Saladin Dr.
Publisher: McGraw-Hill Education
expand_more
expand_more
format_list_bulleted
Concept explainers
Question
Chapter 18, Problem 14TYR
Summary Introduction
Introduction:
The immune system normally serves to protect the body from an outer attack. This protective function primarily depends on distinguishing self (the body’s own cells) from non-self and is crucial to a healthy immune system. The recognizing capacity of the immune system is possible due to the presence of large molecules called antigens, which are expressed and displayed on all cells’ surfaces.
An application of the antigen–antibody reaction is when blood is essential to be transfused from a donor to a recipient. The occurrence or lack of antigens and antibodies on the erythrocytes and in the plasma of the donor and recipient needs to be considered to avoid a potentially life-threatening transfusion reaction.
Expert Solution & Answer
Want to see the full answer?
Check out a sample textbook solution
Students have asked these similar questions
Joden Koepp
olor in chickens is due to incomplete dominance. BB = Black chicken, WW = White
BLOOD TYPES
Arhite chicken is
In humans, Rh positive blood is dominant (R) over Rh negative blood (r). A man with type 0, Rh positive
blood (whose mother had Rh negative blood), marries a woman with type AB, Rh negative blood. Several
children were born.
is?
R
R
Genotypes
Phenotypes
RRR
RR Rr
Rr
4/16 RR
R RR RK Rr
Rr
4/16 rr
3/4 Rh posi
1/4 Rh negu
1/2 Rr
rr
rr
rrrr
88
888
75
e genotype of the man?
the genotype of the woman?
The mother of the man had type AB blood.
Please indentify the unknown organism
Please indentify the unknown organism
Chapter 18 Solutions
Anatomy & Physiology: The Unity of Form and Function (Standalone Book)
Ch. 18.1 - Prob. 1BYGOCh. 18.1 - Prob. 2BYGOCh. 18.1 - Prob. 3BYGOCh. 18.1 - Prob. 4BYGOCh. 18.1 - Prob. 5BYGOCh. 18.1 - Prob. 1AYLOCh. 18.1 - Prob. 2AYLOCh. 18.1 - Prob. 3AYLOCh. 18.1 - Prob. 4AYLOCh. 18.1 - Prob. 5AYLO
Ch. 18.1 - Prob. 6AYLOCh. 18.1 - Prob. 7AYLOCh. 18.2 - Prob. 6BYGOCh. 18.2 - Prob. 7BYGOCh. 18.2 - Prob. 8BYGOCh. 18.2 - Prob. 9BYGOCh. 18.2 - Prob. 10BYGOCh. 18.2 - Prob. 11BYGOCh. 18.2 - Prob. 12BYGOCh. 18.2 - Prob. 1AYLOCh. 18.2 - Prob. 2AYLOCh. 18.2 - Prob. 3AYLOCh. 18.2 - Prob. 4AYLOCh. 18.2 - Prob. 5AYLOCh. 18.2 - Prob. 6AYLOCh. 18.2 - Prob. 7AYLOCh. 18.2 - Prob. 8AYLOCh. 18.2 - Prob. 9AYLOCh. 18.2 - Prob. 10AYLOCh. 18.2 - Prob. 11AYLOCh. 18.3 - Prob. 13BYGOCh. 18.3 - Prob. 14BYGOCh. 18.3 - Prob. 15BYGOCh. 18.3 - Prob. 16BYGOCh. 18.3 - Prob. 1AYLOCh. 18.3 - Prob. 2AYLOCh. 18.3 - Prob. 3AYLOCh. 18.3 - Prob. 4AYLOCh. 18.3 - Prob. 5AYLOCh. 18.3 - Prob. 6AYLOCh. 18.3 - Prob. 7AYLOCh. 18.4 - Prob. 17BYGOCh. 18.4 - Prob. 18BYGOCh. 18.4 - Prob. 19BYGOCh. 18.4 - Prob. 20BYGOCh. 18.4 - Prob. 21BYGOCh. 18.4 - Prob. 1AYLOCh. 18.4 - Prob. 2AYLOCh. 18.4 - Prob. 3AYLOCh. 18.4 - Prob. 4AYLOCh. 18.4 - Prob. 5AYLOCh. 18.4 - Prob. 6AYLOCh. 18.4 - Prob. 7AYLOCh. 18.5 - Prob. 22BYGOCh. 18.5 - Prob. 23BYGOCh. 18.5 - Prob. 24BYGOCh. 18.5 - Prob. 25BYGOCh. 18.5 - Prob. 26BYGOCh. 18.5 - Prob. 1AYLOCh. 18.5 - Prob. 2AYLOCh. 18.5 - Prob. 3AYLOCh. 18.5 - Prob. 4AYLOCh. 18.5 - Prob. 5AYLOCh. 18.5 - Prob. 6AYLOCh. 18.5 - Prob. 7AYLOCh. 18.5 - Prob. 8AYLOCh. 18.5 - Prob. 9AYLOCh. 18.5 - Prob. 10AYLOCh. 18.5 - Prob. 11AYLOCh. 18.5 - Prob. 12AYLOCh. 18.5 - Prob. 13AYLOCh. 18 - Antibodies belong to a class of plasma proteins...Ch. 18 - Prob. 2TYRCh. 18 - Prob. 3TYRCh. 18 - Prob. 4TYRCh. 18 - Prob. 5TYRCh. 18 - Prob. 6TYRCh. 18 - Prob. 7TYRCh. 18 - Prob. 8TYRCh. 18 - Prob. 9TYRCh. 18 - Prob. 10TYRCh. 18 - Prob. 11TYRCh. 18 - Prob. 12TYRCh. 18 - Prob. 13TYRCh. 18 - Prob. 14TYRCh. 18 - Prob. 15TYRCh. 18 - Prob. 16TYRCh. 18 - Prob. 17TYRCh. 18 - Prob. 18TYRCh. 18 - Prob. 19TYRCh. 18 - Prob. 20TYRCh. 18 - Prob. 1BYMVCh. 18 - Prob. 2BYMVCh. 18 - Prob. 3BYMVCh. 18 - Prob. 4BYMVCh. 18 - Prob. 5BYMVCh. 18 - Prob. 6BYMVCh. 18 - Prob. 7BYMVCh. 18 - Prob. 8BYMVCh. 18 - Prob. 9BYMVCh. 18 - Prob. 10BYMVCh. 18 - Prob. 1TFCh. 18 - Prob. 2TFCh. 18 - Prob. 3TFCh. 18 - Prob. 4TFCh. 18 - Prob. 5TFCh. 18 - Prob. 6TFCh. 18 - Prob. 7TFCh. 18 - Prob. 8TFCh. 18 - When RBCs die and break down, the globin moiety of...Ch. 18 - Prob. 10TFCh. 18 - Prob. 1TYCCh. 18 - Prob. 2TYCCh. 18 - Prob. 3TYCCh. 18 - Prob. 4TYCCh. 18 - Prob. 5TYC
Knowledge Booster
Learn more about
Need a deep-dive on the concept behind this application? Look no further. Learn more about this topic, biology and related others by exploring similar questions and additional content below.Similar questions
- Please indentify the unknown organismarrow_forwardPlease indentify the unknown organismarrow_forward5G JA ATTC 3 3 CTIA A1G5 5 GAAT I I3 3 CTIA AA5 Fig. 5-3: The Eco restriction site (left) would be cleaved at the locations indicated by the arrows. However, a SNP in the position shown in gray (right) would prevent cleavage at this site by EcoRI One of the SNPs in B. rapa is found within the Park14 locus and can be detected by RFLP analysis. The CT polymorphism is found in the intron of the Bra013780 gene found on Chromosome 1. The Park14 allele with the "C" in the SNP has two EcoRI sites and thus is cleaved twice by EcoRI If there is a "T" in that SNP, one of the EcoRI sites is altered, so the Park14 allele with the T in the SNP has only one EcoRI site (Fig. 5-3). Park14 allele with SNP(C) Park14 allele with SNPT) 839 EcoRI 1101 EcoRI 839 EcoRI Fig. 5.4: Schematic restriction maps of the two different Park14 alleles (1316 bp long) of B. rapa. Where on these maps is the CT SNP located? 90 The primers used to amplify the DNA at the Park14 locus (see Fig. 5 and Table 3 of Slankster et…arrow_forward
- From your previous experiment, you found that this enhancer activates stripe 2 of eve expression. When you sequence this enhancer you find several binding sites for the gap gene, Giant. To test how Giant interacts with eve, you decide to remove all of the Giant binding sites from the eve enhancer. What results do you expect to see with respect to eve expression?arrow_forwardWhat experiment could you do to see if the maternal gene, bicoid, is sufficient to form anterior fates?arrow_forwardYou’re curious about the effect that gap genes have on the pair-rule gene, evenskipped (eve), so you isolate and sequence each of the eve enhancers. You’re particularly interested in one of the enhancers, which is just upstream of the eve gene. Describe an experimental technique you would use to find out where this particular eve enhancer is active.arrow_forward
- For short answer questions, write your answers on the line provided. To the right is the mRNA codon table to use as needed throughout the exam. First letter U บบบ U CA UUCPhe UUA UCU Phe UCC UUG Leu CUU UAU. G U UAC TV UGCys UAA Stop UGA Stop A UAG Stop UGG Trp Ser UCA UCG CCU] 0 CUC CUA CCC CAC CAU His CGU CGC Leu Pro CCA CAA Gin CGA Arg CUG CCG CAG CGG AUU ACU AAU T AUC lle A 1 ACC Thr AUA ACA AUG Mot ACG AGG Arg GUU GCU GUC GCC G Val Ala GAC Asp GGU GGC GUA GUG GCA GCG GAA GGA Gly Glu GAGJ GGG AACASH AGU Ser AAA1 AAG Lys GAU AGA CAL CALUCAO CAO G Third letter 1. (+7) Use the table below to answer the questions; use the codon table above to assist you. The promoter sequence of DNA is on the LEFT. You do not need to fill in the entire table. Assume we are in the middle of a gene sequence (no need to find a start codon). DNA 1 DNA 2 mRNA tRNA Polypeptide C Val G C. T A C a. On which strand of DNA is the template strand (DNA 1 or 2)?_ b. On which side of the mRNA is the 5' end (left or…arrow_forward3. (6 pts) Fill in the boxes according to the directions on the right. Structure R-C R-COOH OH R-OH i R-CO-R' R R-PO4 R-CH3 C. 0 R' R-O-P-OH 1 OH H R-C-H R-N' I- H H R-NH₂ \H Name Propertiesarrow_forward4. (6 pts) Use the molecule below to answer these questions and identify the side chains and ends. Please use tidy boxes to indicate parts and write the letter labels within that box. a. How many monomer subunits are shown? b. Box a Polar but non-ionizable side chain and label P c. Box a Basic Polar side chain and label BP d. Box the carboxyl group at the end of the polypeptide and label with letter C (C-terminus) H H OHHO H H 0 HHO H-N-CC-N-C-C N-C-C-N-GC-OH I H-C-H CH2 CH2 CH2 H3C-C+H CH2 CH2 OH CH CH₂ C=O OH CH2 NH2arrow_forward
arrow_back_ios
SEE MORE QUESTIONS
arrow_forward_ios
Recommended textbooks for you
Medical Terminology for Health Professions, Spira...Health & NutritionISBN:9781305634350Author:Ann Ehrlich, Carol L. Schroeder, Laura Ehrlich, Katrina A. SchroederPublisher:Cengage Learning
Understanding Health Insurance: A Guide to Billin...Health & NutritionISBN:9781337679480Author:GREENPublisher:Cengage
Comprehensive Medical Assisting: Administrative a...NursingISBN:9781305964792Author:Wilburta Q. Lindh, Carol D. Tamparo, Barbara M. Dahl, Julie Morris, Cindy CorreaPublisher:Cengage Learning
Medical Terminology for Health Professions, Spira...
Health & Nutrition
ISBN:9781305634350
Author:Ann Ehrlich, Carol L. Schroeder, Laura Ehrlich, Katrina A. Schroeder
Publisher:Cengage Learning
Understanding Health Insurance: A Guide to Billin...
Health & Nutrition
ISBN:9781337679480
Author:GREEN
Publisher:Cengage
Comprehensive Medical Assisting: Administrative a...
Nursing
ISBN:9781305964792
Author:Wilburta Q. Lindh, Carol D. Tamparo, Barbara M. Dahl, Julie Morris, Cindy Correa
Publisher:Cengage Learning